CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −4,104 | $23.22 | $95K | 235,047 |
| 2025-12-31 | REICIN ALISE Chief Executive Officer | Option exercise | +10,966 | $2.38 | $26K | 239,151 |
| 2025-12-31 | REICIN ALISE Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,966 | 22,957 | ||
| 2025-12-22 | McNamara Peter Chief Scientific Officer | Option exercise | +7,000 | $2.98 | $21K | 40,879 |
| 2025-12-22 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) | −7,000 | 25,065 | ||
| 2025-09-25 | Ruddy Marcella K. Chief Medical Officer | Grant or award | +5,370 | 55,311 | ||
| 2025-09-25 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +9,750 | 9,750 | ||
| 2025-09-25 | McNamara Peter Chief Scientific Officer | Grant or award | +4,550 | 33,879 | ||
| 2025-09-25 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +8,260 | 8,260 | ||
| 2025-09-25 | Schwabish Marc Chief Business Officer | Grant or award | +4,210 | 22,933 | ||
| 2025-09-25 | Schwabish Marc Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,650 | 7,650 | ||
| 2025-09-25 | Lochner Daniel Chief Financial Officer | Grant or award | +5,430 | 28,121 | ||
| 2025-09-25 | Lochner Daniel Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +9,860 | 9,860 | ||
| 2025-09-25 | REICIN ALISE Chief Executive Officer | Grant or award | +14,700 | 228,185 | ||
| 2025-09-25 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +26,710 | 26,710 | ||
| 2025-06-20 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −859 | $19.81 | $17K | 213,485 |
| 2025-06-09 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2025-06-09 | Vitorovic Stefan Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2025-06-09 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2025-06-09 | Tipirneni Praveen P. Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 |
Page 4 of 10 · 188 trades